nach oben

Erschienen in:

01.12.2012 | CME Zertifizierte Fortbildung

Diagnostik der koronaren Herzkrankheit

Stellenwert der verschiedenen bildgebenden Verfahren

verfasst von: Prof. Dr. H. Thiele, R. Dörr, M. Gutberlet

Erschienen in: Herz | Ausgabe 8/2012

Einloggen, um Zugang zu erhalten

Zusammenfassung

In diesem CME-Beitrag werden die verschiedenen nicht-invasiven bildgebenden Methoden unter Ausklammerung der Positronenemissionstomographie (PET) zur Ischämie- und auch Vitalitätsdiagnostik beschrieben. Neben der Beurteilung der funktionellen Relevanz einer Stenose durch Stressmethoden wie der Stressechokardiographie, der Myokardszintigraphie oder der Stressmagnetresonanztomographie bietet insbesondere die Multislice-Computertomographie die Möglichkeit der nicht-invasiven Darstellung der Koronarien mit eventuellen Stenosen. Die neuere Hybridbildgebung kann die Koronaranatomie mit einer möglichen gleichzeitigen Ischämie simultan darstellen. Die Vor- und Nachteile der einzelnen Verfahren für die Ischämie- und Vitalitätsdiagnostik werden dargestellt.

Nur mit Berechtigung zugänglich

Fox K, Garcia MAA, Ardissino D et al (2006) Guidelines on the management of stable angina pectoris: executive summary. Eur Heart J 27:1341–1381PubMedCrossRef

Achenbach S, Barkhausen J, Beer M et al (2012) Consensus recommendations of the German Radiology Society (DRG), the German Cardiac Society (DGK) and the German Society for Pediatric Cardiology (DGPK) on the use of cardiac imaging with computed tomography and magnetic resonance imaging. Rofo 184:345–368PubMedCrossRef

Ferket BS, Genders TSS, Colkesen EB et al (2011) Systematic review of guidelines on imaging of asymptomatic coronary artery disease. J Am Coll Cardiol 57:1591–1600PubMedCrossRef

Bonow RO, Maurer G, Lee KL et al (2011) Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med 364:1617–1625PubMedCrossRef

Desch S, Eitel I, De Waha S et al (2011) Cardiac magnetic resonance imaging parameters as surrogate endpoints in clinical trials of acute myocardial infarction. Trials 12:e204–e215CrossRef

Gaemperli O, Bengel FM, Kaufmann PA (2011) Cardiac hybrid imaging. Eur Heart J 32:2100–2108PubMedCrossRef

Cerqueira MD, Weissman NJ, Dilsizian V et al (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. Circulation 105:539–542PubMedCrossRef

Pellikka PA, Nagueh SF, Elhendy AA et al (2007) American Society of Echocardiography recommendations for performance, interpretation, and application of stress echocardiography. J Am Soc Echocardiogr 20:1021–1041PubMedCrossRef

Fine NM, Pellikka PA (2011) Stress echocardiography for the detection and assessment of coronary artery disease. J Nucl Cardiol 18:501–515PubMedCrossRef

10.

Metz LD, Beattie M, Hom R et al (2007) The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography: a metaanalysis. J Am Coll Cardiol 49:227–237PubMedCrossRef

11.

Cerqueira MD, Nguyen P, Staehr P et al (2008) Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging: Integrated ADVANCE-MPI trial results. JACC Cardiovascular Imaging 1:307–316PubMedCrossRef

12.

Iskandrian AE, Bateman TM, Belardinelli L et al (2007) Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial. J Nucl Cardiol 14:645–658PubMedCrossRef

13.

Schäfers M, Bengel F, Büll U et al (2009) Position paper nuclear cardiology: update 2008. Nuklearmedizin 48:55–78

14.

Jaarsma C, Leiner T, Bekkers SC et al (2012) Diagnostic performance of noninvasive myocardial perfusion imaging using single-photon emission computed tomography, cardiac magnetic resonance, and positron emission tomography imaging for the detection of obstructive coronary artery disease: a meta-analysis. J Am Coll Cardiol 59:1719–1728PubMedCrossRef

15.

Bateman TM, Cullom SJ (2005) Attenuation correction single-photon emission computed tomography myocardial perfusion imaging. Semin Nucl Med 35:37–51PubMedCrossRef

16.

Genovesi D, Giorgetti A, Gimelli A et al (2011) Impact of attenuation correction and gated acquisition in SPECT myocardial perfusion imaging: results of the multicentre SPAG (SPECT Attenuation Correction vs Gated) study. Eur J Nucl Med Mol Imaging 38:1890–1898PubMedCrossRef

17.

Sharir T, Germano G, Kavanagh PB et al (1999) Incremental prognostic value of post-stress left ventricular ejection fraction and volume by gated myocardial perfusion single photon emission computed tomography. Circulation 100:1035–1042PubMedCrossRef

18.

Shaw LJ, Iskandrian AE (2004) Prognostic value of gated myocardial perfusion SPECT. J Nucl Cardiol 11:171–185PubMedCrossRef

19.

Underwood SR, Anagnostopoulos C, Cerqueira M et al (2004) Myocardial perfusion scintigraphy: the evidence. Eur J Nucl Med Mol Imaging 31:261–291PubMedCrossRef

20.

Metz LD, Beattie M, Hom R et al (2007) The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography: a meta-analysis. J Am Coll Card 49:227–237CrossRef

21.

Underwood SR, Godman B, Salyani S et al (1999) Economics of myocardial perfusion imaging in Europe – the EMPIRE Study. Eur Heart J 20:157–166PubMedCrossRef

22.

Hachamovitch R, Hayes SW, Friedman JD et al (2003) Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 107:2900–2907PubMedCrossRef

23.

Hachamovitch R, Rozanski A, Shaw LJ et al (2011) Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy. Eur Heart J 32:1012–1024PubMedCrossRef

24.

Shaw LJ, Berman DS, Maron DJ et al (2008) Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden. Circulation 117:1283–1291PubMedCrossRef

25.

Wijns W, Kolh P, Danchin N et al (2010) Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 31:2501–2555PubMedCrossRef

26.

Bundesärztekammer, Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) (2012) Nationale Versorgungsleitlinie Chronische KHK, Langfassung, Version 1.13, Juli 2012. http://www.versorgungsleitlinien.de/themen/khk/pdf/nvl-khk-lang-1.13.pdf

27.

Slart RH, Bax JJ, Veldhuisen DJ van et al (2006) Imaging techniques in nuclear cardiology for the assessment of myocardial viability. Int J Cardiovasc Imaging 22:63–80PubMedCrossRef

28.

Klein C, Nekolla SG, Bengel FM et al (2002) Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging. Circulation 105:162–167PubMedCrossRef

29.

Raja S, Singh B, Rohit MK et al (2012) Comparison of nitrate augmented Tc-99 m tetrofosmin gated SPECT imaging with FDG PET imaging for the assessment of myocardial viability in patients with severe left ventricular dysfunction. J Nucl Cardiol [Epub ahead of print]

30.

Achenbach S, Giesler T, Ropers D et al (2001) Detection of coronary artery stenoses by contrast-enhanced, retrospectively electrocardiographically-gated, multislice spiral computed tomography. Circulation 103:2535–2538PubMedCrossRef

31.

Leschka S, Alkadhi H, Plass A et al (2005) Accuracy of MSCT coronary angiography with 64-slice technology: first experience. Eur Heart J 26:1482–1487PubMedCrossRef

32.

Achenbach S, Daniel WG (2007) Current role of cardiac computed tomography. Herz 32:97–107PubMedCrossRef

33.

Salavati A, Radmanesh F, Heidari K et al (2012) Dual-source computed tomography angiography for diagnosis and assessment of coronary artery disease: systematic review and meta-analysis. J Cardiovasc Comput Tomogr 6:78–90PubMedCrossRef

34.

Miller JM, Rochitte CE, Dewey M et al (2008) Diagnostic performance of coronary angiography by 64-row CT. N Engl J Med 359:2324–2336PubMedCrossRef

35.

Hausleiter J, Meyer T, Hermann F et al (2009) Estimated radiation dose associated with cardiac CT angiography. JAMA 301:500–507PubMedCrossRef

36.

Hausleiter J, Meyer TS, Martuscelli E et al (2012) Image quality and radiation exposure with prospectively ECG-triggered axial scanning for coronary CT angiography: the multicenter, multivendor, randomized PROTECTION-III study. JACC Cardiovasc Imaging 5:484–493PubMedCrossRef

37.

Lehmkuhl L, Herz F, Foldyna B et al (2011) Diagnostic performance of prospectively ECG triggered versus retrospectively ECG gated 64-slice computed tomography coronary angiography in a heterogeneous patient population. Eur J Radiol 80:342–348PubMedCrossRef

38.

Maruyama T, Takada M, Hasuike T et al (2008) Radiation dose reduction and coronary assessability of prospective electrocardiogram-gated computed tomography coronary angiography: comparison with retrospective electrocardiogram-gated helical scan. J Am Coll Card 52:1450–1455CrossRef

39.

Achenbach S, Marwan M, Ropers D et al (2010) Coronary computed tomography angiography with a consistent dose below 1 mSv using prospectively electrocardiogram-triggered high-pitch spiral acquisition. Eur Heart J 31:340–346PubMedCrossRef

40.

Feuchtner G, Goetti R, Plass A et al (2011) Adenosine stress high-pitch 128-slice dual-source myocardial computed tomography perfusion for imaging of reversible myocardial ischemia: comparison with magnetic resonance imaging. Circ Cardiovasc Imaging 4:540–549PubMedCrossRef

41.

Hulten EA, Carbonaro S, Petrillo SP et al (2011) Prognostic value of cardiac computed tomography angiography: a systematic review and meta-analysis. J Am Coll Card 57:1237–1247CrossRef

42.

Nandalur KR, Dwamena BA, Choudhri AF et al (2007) Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease. J Am Coll Cardiol 50:1343–1353PubMedCrossRef

43.

Schwitter J, Wacker CM, Rossum AC van et al (2008) MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J 29:480–489PubMedCrossRef

44.

Schwitter J, Wacker CM, Wilke N et al (2012) MR-IMPACT II: Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coronary artery disease Trial: perfusion-cardiac magnetic resonance vs. single-photon emission computed tomography for the detection of coronary artery disease: a comparative multicentre, multivendor trial. Eur Heart J [Epub ahead of print]

45.

Greenwood JP, Maredia N, Younger JF et al (2012) Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet 379:453–460PubMedCrossRef

46.

Schwitter J, Arai AE (2011) Assessment of cardiac ischaemia and viability: role of cardiovascular magnetic resonance. Eur Heart J 32:799–809PubMedCrossRef

47.

Jerosch-Herold M, Wilke N, Stillman AE (1998) Magnetic resonance quantification of the myocardial perfusion reserve with a Fermi function model for constrained devolution. Med Phys 25:73–84PubMedCrossRef

48.

Nagel E, Klein C, Paetsch I et al (2003) Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease. Circulation 108:432–437PubMedCrossRef

49.

Klem I, Heitner JF, Shah DJ et al (2006) Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging. J Am Coll Cardiol 47:1630–1638PubMedCrossRef

50.

Motwani M, Maredia N, Fairbairn TA et al (2012) High-resolution versus standard-resolution cardiovascular MR myocardial perfusion imaging for the detection of coronary artery disease. Circ Cardiovasc Imaging 5:306–313PubMedCrossRef

51.

Nagel E, Lehmkuhl HB, Bocksch W et al (1999) Non-invasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI – comparison with dobutamine stress echocardiography. Circulation 99:763–770PubMedCrossRef

52.

Korosoglou G, Elhmidi Y, Steen H et al (2010) Prognostic value of high-dose dobutamine stress magnetic resonance imaging in 1,493 consecutive patients: assessment of myocardial wall motion and perfusion. J Am Coll Cardiol 56:1225–1234PubMedCrossRef

53.

Jahnke C, Nagel E, Gebker R et al (2007) Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging. Circulation 115:1769–1776PubMedCrossRef

54.

Kim RJ, Hillenbrand HB, Judd RM (2000) Evaluation of myocardial viability by MRI. Herz 25:417–430PubMedCrossRef

55.

Kim RJ, Wu E, Rafael A et al (2000) The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 343:1445–1453PubMedCrossRef

56.

Gutberlet M, Frohlich M, Mehl S et al (2005) Myocardial viability assessment in patients with highly impaired left ventricular function: comparison of delayed enhancement, dobutamine stress MRI, end-diastolic wall thickness, and TI201-SPECT with functional recovery after revascularization. Eur Radiol 15:872–880PubMedCrossRef

57.

Kim HW, Farzaneh-Far A, Kim RJ (2010) Cardiovascular magnetic resonance in patients with myocardial infarction: current and emerging applications. J Am Coll Cardiol 55:1–16CrossRef

58.

Lin GA, Dudley RA, Lucas FL et al (2008) Frequency of stress testing to document ischemia prior to elective percutaneous coronary intervention. JAMA 300:1765–1773PubMedCrossRef

59.

Flotats A, Knuuti J, Gutberlet M et al (2011) Hybrid cardiac imaging: SPECT/CT and PET/CT. A joint position statement by the European Association of Nuclear Medicine (EANM), the European Society of Cardiac Radiology (ESCR) and the European Council of Nuclear Cardiology (ECNC). Eur J Nucl Med Mol Imaging 38:201–212PubMedCrossRef

60.

Fleischmann KE, Hunink MG, Kuntz KM, Douglas PS (1998) Exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance. JAMA 280:913–920PubMedCrossRef

61.

Hundley WG, Hamilton CA, Thomas MS et al (1999) Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress echocardiography. Circulation 100:1697–1702PubMedCrossRef

Titel: Diagnostik der koronaren Herzkrankheit
Stellenwert der verschiedenen bildgebenden Verfahren
verfasst von: Prof. Dr. H. Thiele
R. Dörr
M. Gutberlet
Publikationsdatum: 01.12.2012
Verlag: Urban and Vogel
Erschienen in: Herz / Ausgabe 8/2012
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI: https://doi.org/10.1007/s00059-012-3688-8

Neu im Fachgebiet Kardiologie

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2012

Antibodies to cardiac receptors

Diabetic cardiomyopathy: ongoing controversies in 2012

Interleukin-6 and E-selectin in acute coronary syndromes and stable angina pectoris

Prophylactic implantable defibrillators in dilated cardiomyopathy